Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy.

Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register

Conference Speakers-
• Christopher Garris-Assistant Professor of Pathology, Massachusetts General Hospital, Harvard Medical School
• Shriya Joshi-Scientist, small molecule drug discovery, Bristol Myers Squibb
• Collin Hudzik-Scientist, EpigenDx
• Allison Drain-Preclinical Development, Affini-T Therapeutics
• Howard Kaufman-President and CEO, Lecturer, Ankyra Therapeutics, Harvard Medical School
• ….more

Become a Speaker @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/speaker-enquiry

Key Highlights-
• Updates in development of ADC’s and Bispecific Ab’s
• Immune Checkpoint Inhibitors and Combinations
• Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
• Biomarkers and Personalized Medicine in IO
• CAR-T Cell therapy, TCR Based-Cell Therapy
• Tumor microenvironment and Oncolytic Viruses

More Links-

Become a Sponsor @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/become-sponsor

Enquire More @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/